Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28763520 | 0.96 | TSHR (0.42) | TSHRALDH1A1TDP1 | |
| SCHEMBL13721473 | 0.96 | TSHR (0.42) | TSHRALDH1A1TDP1 | |
| SCHEMBL28763515 | 0.96 | TSHR (0.42) | TSHRALDH1A1TDP1 | |
| SCHEMBL1184928 | 0.88 | — | — | |
| SCHEMBL377335 | 0.85 | ALDH1A1 (0.33) | TSHRALDH1A1TDP1 | |
| SCHEMBL31327912 | 0.85 | TSHR (0.43) | TSHRALDH1A1TDP1 | |
| SCHEMBL472807 | 0.81 | ALDH1A1 (0.31) | TSHRALDH1A1TDP1 | |
| SCHEMBL9995662 | 0.79 | — | — | |
| SCHEMBL9995783 | 0.79 | — | — | |
| SCHEMBL9474135 | 0.78 | ALDH1A1 (0.32) | TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112694650-B | Wear-resistant bootleg sole and preparation process thereof | 莆田永生鞋业有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-114835733-A | Sp (sp) 2 Preparation method of-C metal organic framework and application of detoxified mustard gas simulant | 南昌大学 | 2022-08-02 | — | — | CN | claimed |
| CN-108623581-B | Method for preparing paninula compound | 中国海洋大学 | 2021-10-22 | — | — | CN | claimed |
| CN-108559100-B | Metal ion guided carboxylic acid ligand functionalized polyacid compound, preparation method thereof and application of catalytic degradation chemical warfare agent simulant | 大连理工大学 | 2021-02-19 | — | — | CN | claimed |
| CN-108627380-B | Method for removing or reducing toxic substance and method for detecting toxic substance | 中国人民解放军军事医学科学院毒物药物研究所 | 2020-10-20 | — | — | CN | claimed |
| CN-110437459-A | A kind of catalytic degradation mustard gas analogies material and preparation method thereof | UNIV ZHENGZHOU | 2019-11-12 | — | — | CN | claimed |
| CN-108627380-A | The method for removing or reducing the method for noxious material and detecting noxious material | 中国人民解放军军事医学科学院毒物药物研究所 | 2018-10-09 | — | — | CN | claimed |
| CN-105879289-B | Using the method for more niobium vanadium oxygen cluster catalyzing oxidizing degrading 2- chloroethylethyl thioethers | 北京理工大学 | 2018-09-25 | — | — | CN | claimed |
| CN-108559100-A | Metal ion guides application of the Carboxylic acid ligand functionalization polyacid compound and preparation method thereof with catalytic degradation chemical warfare agent analogies | 大连理工大学 | 2018-09-21 | — | — | CN | claimed |
| CN-104198603-B | The analysis purposes of sulfydryl class nucleophilic displacement of fluorine derivatization reagent and method | 中国人民解放军军事医学科学院毒物药物研究所 | 2016-09-14 | — | — | CN | claimed |
| CN-105879289-A | Method for catalyzing, oxidizing and degrading 2-chloroethyl ethyl sulfide through multi-niobium-vanadium-oxygen clusters | 北京理工大学 | 2016-08-24 | — | — | CN | claimed |
| WO-2008108803-A9 | IMMUNE CELL BIOSENSORS AND METHODS OF USING SAME | AMAOX LTD (US) | 2008-10-30 | — | — | WO | claimed |
| WO-2008108803-A2 | IMMUNE CELL BIOSENSORS AND METHODS OF USING SAME | AMAOX, LTD. (US) | 2008-09-12 | — | — | WO | claimed |
| US-12600756-B2 | Recombinant modified fibroblast growth factors and therapeutic uses thereof | TREFOIL THERAPEUTICS, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| EP-4621067-A2 | RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF | Trefoil Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-3619324-B1 | RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF | TREFOIL THERAPEUTICS INC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-H414-H | Surface ionization source | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1988-01-05 | — | — | US | disclosed |
| US-4379154-A | Thiocarboxamide derivatives and their use as pharmaceuticals | RHONE-POULENC SANTE (FR) | 1983-04-05 | — | — | US | disclosed |
| US-4349545-A | Novel erythromycin a derivatives | ROUSSEL UCLAF (FR) | 1982-09-14 | — | — | US | disclosed |
| US-3975423-A | Alkylthioalkyl-substituted alkylsulfonylacetonitriles | POLAROID CORPORATION (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600756-B2 | Recombinant modified fibroblast growth factors and therapeutic uses thereof | FGF1, FGF2, FIBP | TSHR 1753/4885ALDH1A1 1752/4885TDP1 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.